Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02213341 · ClinicalTrials.gov registry record
Impact of Vaccination on Th2 Immunity in Infancy
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 77
- Enrollment target
NCT02213341: Clinical Trial study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT02213341 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02213341 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the responses in the immune system of infants after they receive the vaccine against diphtheria, tetanus, and pertussis (DTaP). The investigators will do this by studying the immune cells and allergy responses in the blood prior to and after receipt of the third DTaP vaccine.
Primary Outcome
Magnitude of increase of allergen-specific IgE. For each child, the maximum allergen-specific IgE change to milk, egg, or peanut will be considered as the primary endpoint.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Skin prick allergen test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-06-14 |
Why NCT02213341 stopped before completion
NCT02213341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT02213341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02213341 about?
NCT02213341 is a clinical study titled "Impact of Vaccination on Th2 Immunity in Infancy". The purpose of this study is to assess the responses in the immune system of infants after they receive the vaccine against diphtheria, tetanus, and pertussis (DTaP). The investigators will do this by studying the immune cells and allergy responses in the blood prior to and after receipt of the thir...
What is the current status of trial NCT02213341?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2015-01. Estimated completion is 2016-06-14.
What interventions are being tested in trial NCT02213341?
The interventions under investigation include: Blood draw (PROCEDURE), Skin prick allergen test (PROCEDURE).
Who is sponsoring clinical trial NCT02213341?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia